The curriculum is fairly explicit here, asking us to describe 'the anaesthetic management of common surgical procedures and their complications...including the TURP syndrome'.
A CRQ from March 2021 was on TURP (80% pass rate) and although TURP syndrome isn't explicitly mentioned in the feedback, I'd hazard it formed part of the question.
As [Na+] falls to below 120mmol/L, cardiac signs start to manifest
Myocardial contractility is impaired further, exacerbating hypotension and bradycardia from fluid overload
ECG changes occur e.g. broadened QRS
Eventually cardiac arrest will ensue, particularly if [Na+] is <100mmol/L
Glycine
Glycine is an inhibitory neurotransmitter with a terminal half-life of 45mins - 3hrs
It is metabolised by oxidative deamination to glyoxylic acid and ammonia by the liver & kidneys
TURP syndrome typically occurs when glycine concentration is >60mmol/L
Leads to nausea, headache, weakness and visual disturbances
Glycine itself causes cardiac myocyte oedema, depressed myocardial contractility and ischaemic ECG changes, further exacerbating cardiac failure
It also enhances NMDA pathway activity, adding to the encephalopathy and eventual seizures of TURP syndrome
Ammonia from glycine metabolism exacerbates the encephalopathy
It causes retinal toxicity, leading to transient blindness
Cardiovascular
Bradycardia
Initial hypertension with wide pulse pressure and raised CVP
Subsequent hypotension as the cardiovascular system is pushed along the Starling curve into cardiac failure
Angina
ECG changes: broadened QRS, ST elevation, U-waves
Cardiovascular collapse and VF/VT
Neurological
Mild symptoms such as apprehension, disorientation, restlessness, confusion
Nausea and vomiting from hyponatraemia and cerebral oedema
Visual disturbance; transient blindness is a feature of glycine toxicity
Seizures and coma
Other
Respiratory distress from pulmonary oedema
Abdominal pain
TURP syndrome is an anaesthetic emergency and I would seek senior anaesthetic support as well as making a rapid but thorough assessment of the patient
Immediate management
Stop surgery and fluids (irrigation and IV)
Apply 100% oxygen
Call for senior help
ABCDE approach:
Maintain airway, may require I&V
Apply 100% oxygen
Treat bradycardia (glycopyrrolate) and hypotension (vasopressors, adrenaline)
Treat seizures with anticonvulsants (e.g. IV lorazepam 4mg) and IV magnesium (Mg2+ inhibits glycine-induced potentiation of NMDA receptor activity)
Can use diuretics e.g. furosemide 40mg to treat hypervolaemia/pulmonary oedema although may cause worsening of hyponatraemia, mannitol causes less hyponatraemia
Severe hyponatraemia (<120mmol/L) or severe symptoms can be treated by increasing intravascular fluid tonicity to reduce cerebral oedema
E.g. hypertonic saline (2.7%), 8.4% NaHCO3 or haemofiltration (in patients with CKD in whom large fluid volumes wish to be avoided)
Aim to increase Na+ by 0.5 - 1mmol/L/hr for the first 24hrs to reduce risk of worsening oedema/central pontine myelinolysis
Subsequent management
HDU/ICU as may need invasive monitoring to monitor fluid shifts, frequent blood sampling